In this real-life study, we evaluated the concordance of the cobas 4800 BRAF V600 Mutation Test relative to the home brew methods (HBM) used at 12 participating INCa platforms when tested in parallel for BRAF genotyping in melanoma samples. This evidence concerns the gene BRAF and melanoma.